Dr Ferenc Scheeren
Published: 16 January 2026
Wednesday, 3 June 2026, 1-2pm
- Assistant Professor (Leiden University Medical Center (LUMC))
- Location: Common Room, Sir Graeme Davies Building
Title: Engineering Smarter Antibodies: Conjugation Strategies and Target PTMs
Synopsis: TBC
Bio:
Ferenc A. Scheeren, PhD is a tenured Assistant Professor at the Leiden University Medical Center (LUMC), where he leads a research program at the interface of antibody engineering and immuno-oncology. His work focuses on developing precision genetic and protein engineering tools to enhance immune targeting, including innovative antibody conjugation strategies and approaches to address post‑translational modifications on target proteins. He has contributed to key advances such as CRISPR-based antibody engineering platforms and the discovery of enzymatic modifier of the CD47 immune checkpoint. Dr. Scheeren’s research has translated into clinical impact, including contributions to the development of therapeutic antibodies such as Nirsevimab and Magrolimab. His lab combines interdisciplinary collaboration with a strong commitment to open science and translational innovation.
First published: 16 January 2026
<< Seminars